Pharmaceuticals
Company Overview of Edge Therapeutics, Inc.
Executive Profile
R. Loch MacDonald M.D., Ph.D.Co-Founder, Chief Scientific Officer and Director, Edge Therapeutics, Inc. |
| Age | Total Calculated Compensation | This person is connected to 1 Board Members in 1 different organizations across 1 different industries. See Board Relationships |
| -- | -- |
Background
Dr. R. Loch MacDonald, M.D., Ph.D. co-founded Edge Therapeutics, Inc. in 2009 and serves as Chief Scientific Officer. Dr. Macdonald is widely considered as a top expert in the world on cerebral vasospasm. His 20 years of unrelenting research has led Edge Therapeutics to its first product, NimoGel, to cure vasospasm. Recent articles published by Dr. Macdonald are Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1), ...
Corporate Headquarters211 Warren StreetNewark, New Jersey 07103 United States Phone: 908-531-4566 Fax: 800-208-3433 Board Members MembershipsCo-Founder, Chief Scientific Officer and Director
EducationUnknown/Other Education University of Toronto PhD University Of Alberta
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Austin, TX | Publicis Touchpoint SolutionsPosted: May 21
- Fairfax, VA | Clinical Review GroupPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
To contact Edge Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








